Pelvic floor Disorders Network-Data Coordinating Center
盆底疾病网络-数据协调中心
基本信息
- 批准号:7485583
- 负责人:
- 金额:$ 266.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-01 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:AbdomenAdverse eventAdvisory CommitteesAncillary StudyBiometryCase Report FormCertificationClinicalClinical DataCollaborationsCommunicationConditionConduct Clinical TrialsDataData Coordinating CenterData QualityDatabasesDiagnosticDocumentationElectronic MailEvaluationFecal IncontinenceFemaleFundingGeneric DrugsGoalsHealth Services ResearchIncontinenceInternetInterviewLaboratoriesLiving CostsManualsMeasurementMichiganMonitorMorbidity - disease rateNumbersOnline SystemsOperative Surgical ProceduresOrganOutcomePatient RecruitmentsPatientsPelvic Floor DisordersPelvisPersonal SatisfactionPoliciesPreparationProceduresProtocols documentationPtosisPublicationsQuality of lifeRandomizedRandomized Clinical TrialsReportingResearch InfrastructureResearch PersonnelSamplingSchemeSiteStandardizationStatistical Data InterpretationStress Urinary IncontinenceStructureTeleconferencesTelephone InterviewsTherapy EvaluationTrainingTreatment outcomeUnited StatesUnited States Food and Drug AdministrationUnited States National Institutes of HealthUniversitiesUrinary IncontinenceUrologyVaginaWomanWorkWritingclinical research sitedemographicsdesignexperienceinstrumentprotocol development
项目摘要
DESCRIPTION (provided by applicant): Pelvic floor disorders, such as urinary incontinence, pelvic organ prolapse, and fecal incontinence, are common and significant health-related problems for women in the United States. Outcomes following surgical and non-surgical intervention for pelvic floor disorders have not been adequately evaluated. As a result, data necessary to fully inform patients and to make important policy decisions are unavailable. The long-term objective of the Pelvic Floor Disorders Network (PFDN) is to systematically evaluate these outcomes. This application to be the Data Coordinating Center (DCC) for the pelvic floor disorders network brings together experienced investigators from biostatistics, urogynecology, urology, quality of life and health services research to prospectively assess the outcomes from various surgical interventions for female pelvic floor disorders. The specific aims of the DCC are to: 1. Assist in protocol development by providing expertise in the design, conduct and analysis of clinical trials conducted by the PFDN. 2. Provide expertise in measurement of quality of life and in the selection of the appropriate instruments to assess treatment outcomes and, when appropriate, to perform the interviews. 3. Coordinate the implementation of the study protocols approved by the Steering Committee, including design of the case report forms and interviewing protocols, development of a manual of operations, centralized database management with either centralized or remote data entry, submission of an IND to the FDA when necessary, and by organizing training and certification sessions, as needed. 4. Establish a database for each study conducted by the PFDN. 5. Implement either centralized or web-based data entry and verification. 6. Monitor the clinical sites with respect to data quality. 7. Provide infrastructure for monitoring adverse events and regulatory oversight for the network. 8. Provide logistical support for the Steering Committee, Advisory Board and DSMB, for both face-to-face meetings and teleconferences. 9. Maintain a website for the PFDN that includes web pages with content for the public, and a password- protected site with all study documentation and databases. 10. Manage and distribute protocol funds to the Clinical Centers. To illustrate the work of the DCC, a randomized clinical trial is proposed to compare surgical procedures for pelvic organ prolapse using a vaginal approach.
描述(由申请人提供): 骨盆底疾病,如尿失禁,盆腔器官脱垂和大便失禁,是美国妇女常见的和重要的健康相关问题。手术和非手术介入治疗骨盆底疾病的结局尚未得到充分评价。因此,无法获得充分告知患者和做出重要政策决定所需的数据。骨盆底疾病网络(PFDN)的长期目标是系统地评估这些结果。该应用程序将成为盆底疾病网络的数据协调中心(DCC),汇集了来自生物统计学,泌尿妇科学,泌尿学,生活质量和健康服务研究的经验丰富的研究人员,以前瞻性地评估女性盆底疾病的各种手术干预的结果。发展协调委员会的具体目标是:1.通过在PFDN进行的临床试验的设计、实施和分析方面提供专业知识,协助方案制定。2.提供生活质量测量和选择适当工具评估治疗结果的专业知识,并在适当时进行访谈。3.协调指导委员会批准的研究方案的实施,包括病例报告表和访谈方案的设计、操作手册的制定、通过集中或远程数据输入进行集中数据库管理、必要时向FDA提交IND以及根据需要组织培训和认证会议。4.为PFDN进行的每项研究建立数据库。5.实施集中或基于网络的数据输入和验证。6.监测临床研究中心的数据质量。7.为监测不良事件和监管网络提供基础设施。8.为指导委员会、咨询委员会和DSMB的面对面会议和电话会议提供后勤支持。9.为PFDN维护一个网站,其中包括面向公众的网页内容,以及一个包含所有研究文件和数据库的密码保护网站。10.管理并向临床中心分发方案资金。为了说明DCC的工作,提出了一项随机临床试验,以比较阴道入路治疗盆腔器官脱垂的手术方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Catherine A Spino其他文献
Catherine A Spino的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Catherine A Spino', 18)}}的其他基金
2/2 Doxycycline for Emphysema in People Living with HIV: The DEPTH Trial
2/2 强力霉素治疗艾滋病毒感染者肺气肿:DEPTH 试验
- 批准号:
10490292 - 财政年份:2021
- 资助金额:
$ 266.87万 - 项目类别:
Core D: Biostatistics and Data Management Core
核心 D:生物统计学和数据管理核心
- 批准号:
10493257 - 财政年份:2021
- 资助金额:
$ 266.87万 - 项目类别:
2/2 Doxycycline for Emphysema in People Living with HIV: The DEPTH Trial
2/2 强力霉素治疗艾滋病毒感染者肺气肿:DEPTH 试验
- 批准号:
10259962 - 财政年份:2021
- 资助金额:
$ 266.87万 - 项目类别:
Core D: Biostatistics and Data Management Core
核心 D:生物统计学和数据管理核心
- 批准号:
10282004 - 财政年份:2021
- 资助金额:
$ 266.87万 - 项目类别:
2/2 Doxycycline for Emphysema in People Living with HIV: The DEPTH Trial
2/2 强力霉素治疗艾滋病毒感染者肺气肿:DEPTH 试验
- 批准号:
10703239 - 财政年份:2021
- 资助金额:
$ 266.87万 - 项目类别:
Core D: Biostatistics and Data Management Core
核心 D:生物统计学和数据管理核心
- 批准号:
10672412 - 财政年份:2021
- 资助金额:
$ 266.87万 - 项目类别:
University of Michigan Data Coordinating Center for the Diabetic Foot Consortium
密歇根大学糖尿病足联盟数据协调中心
- 批准号:
10685713 - 财政年份:2019
- 资助金额:
$ 266.87万 - 项目类别:
University of Michigan Data Coordinating Center for the Diabetic Foot Consortium
密歇根大学糖尿病足联盟数据协调中心
- 批准号:
10877641 - 财政年份:2019
- 资助金额:
$ 266.87万 - 项目类别:
University of Michigan Data Coordinating Center for the Diabetic Foot Consortium
密歇根大学糖尿病足联盟数据协调中心
- 批准号:
10208881 - 财政年份:2019
- 资助金额:
$ 266.87万 - 项目类别:
University of Michigan Data Coordinating Center for the Diabetic Foot Consortium
密歇根大学糖尿病足联盟数据协调中心
- 批准号:
10614917 - 财政年份:2019
- 资助金额:
$ 266.87万 - 项目类别:
相似海外基金
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10707830 - 财政年份:2023
- 资助金额:
$ 266.87万 - 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
- 批准号:
479728 - 财政年份:2023
- 资助金额:
$ 266.87万 - 项目类别:
Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
- 批准号:
10884567 - 财政年份:2023
- 资助金额:
$ 266.87万 - 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
- 批准号:
10751964 - 财政年份:2023
- 资助金额:
$ 266.87万 - 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
- 批准号:
486321 - 财政年份:2022
- 资助金额:
$ 266.87万 - 项目类别:
Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10676786 - 财政年份:2022
- 资助金额:
$ 266.87万 - 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10440970 - 财政年份:2022
- 资助金额:
$ 266.87万 - 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
- 批准号:
10642998 - 财政年份:2022
- 资助金额:
$ 266.87万 - 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10482465 - 财政年份:2022
- 资助金额:
$ 266.87万 - 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
- 批准号:
10191053 - 财政年份:2020
- 资助金额:
$ 266.87万 - 项目类别:














{{item.name}}会员




